Cannabis and Cognition: Connecting the Dots towards the Understanding of the Relationship
Abstract
:Conflicts of Interest
References
- National Academies of Sciences, Engineering, and Medicine. The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research; The National Academies Press: Washington, DC, USA, 2017. [Google Scholar]
- Colizzi, M.; Bhattacharyya, S. Cannabis use and the development of tolerance: A systematic review of human evidence. Neurosci. Biobehav. Rev. 2018, 93, 1–25. [Google Scholar] [CrossRef] [Green Version]
- Colizzi, M.; Weltens, N.; McGuire, P.; Lythgoe, D.; Williams, S.; Van Oudenhove, L.; Bhattacharyya, S. Delta-9-tetrahydrocannabinol increases striatal glutamate levels in healthy individuals: Implications for psychosis. Mol. Psychiatry 2019, 1. [Google Scholar] [CrossRef]
- Degenhardt, L.; Ferrari, A.J.; Calabria, B.; Hall, W.D.; Norman, R.E.; McGrath, J.J.; Flaxman, A.D.; Engell, R.E.; Freedman, G.D.; Whiteford, H.A.; et al. The Global Epidemiology and Contribution of Cannabis Use and Dependence to the Global Burden of Disease: Results from the GBD 2010 Study. PLoS ONE 2013, 8, e76635. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Nutt, D.J.; A King, L.; Saulsbury, W.; Blakemore, C. Development of a rational scale to assess the harm of drugs of potential misuse. Lancet 2007, 369, 1047–1053. [Google Scholar] [CrossRef]
- Colizzi, M.; Bhattacharyya, S. Neurocognitive effects of cannabis: Lessons learned from human experimental studies. Prog. Brain Res. 2018, 242, 179–216. [Google Scholar] [PubMed]
- Lovell, M.; Akhurst, J.; Padgett, C.; Garry, M.I.; Matthews, A. Cognitive outcomes associated with long-term, regular, recreational cannabis use in adults: A meta-analysis. Exp. Clin. Psychopharmacol. 2019. [Google Scholar] [CrossRef] [PubMed]
- Taurisano, P.; Antonucci, L.A.; Fazio, L.; Rampino, A.; Romano, R.; Porcelli, A.; Masellis, R.; Colizzi, M.; Quarto, T.; Torretta, S.; et al. Prefrontal activity during working memory is modulated by the interaction of variation in CB1 and COX2 coding genes and correlates with frequency of cannabis use. Cortex 2016, 81, 231–238. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Colizzi, M.; Fazio, L.; Ferranti, L.; Porcelli, A.; Masellis, R.; Marvulli, D.; Bonvino, A.; Ursini, G.; Blasi, G.; Bertolino, A. Functional genetic variation of the cannabinoid receptor I and cannabis use interact on prefrontal connectivity and related working memory behavior. Neuropsychopharmacology 2015, 40, 640–649. [Google Scholar] [CrossRef] [Green Version]
- Colizzi, M.; McGuire, P.; Giampietro, V.; Williams, S.; Brammer, M.; Bhattacharyya, S. Previous cannabis exposure modulates the acute effects of delta-9-tetrahydrocannabinol on attentional salience and fear processing. Exp. Clin. Psychopharmacol. 2018, 26, 582–598. [Google Scholar] [CrossRef]
- Colizzi, M.; McGuire, P.; Giampietro, V.; Williams, S.C.; Brammer, M.; Bhattacharyya, S. Modulation of acute effects of delta-9-tetrahydrocannabinol on psychotomimetic effects, cognition and brain function by previous cannabis exposure. Eur. Neuropsychopharmacol. 2018, 28, 850–862. [Google Scholar] [CrossRef] [Green Version]
- Colizzi, M.; Bhattacharyya, S. Does Cannabis Composition Matter? Differential Effects of Delta-9-tetrahydrocannabinol and Cannabidiol on Human Cognition. Curr. Addict. Rep. 2017, 4, 62–74. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Meier, M.H.; Caspi, A.; Ambler, A.; Harrington, H.; Houts, R.; Keefe, R.S.E.; McDonald, K.; Ward, A.; Poulton, R.; Moffitt, T. Persistent cannabis users show neuropsychological decline from childhood to midlife. Proc. Natl. Acad. Sci. USA 2012, 109, E2657–E2664. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Altıntaş, M.; Inanc, L.; Oruc, G.A.; Arpacioglu, S.; Gulec, H. Clinical characteristics of synthetic cannabinoid-induced psychosis in relation to schizophrenia: A single-center cross-sectional analysis of concurrently hospitalized patients. Neuropsychiatr. Dis. Treat. 2016, 12, 1893–1900. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Hurd, Y.L.; Manzoni, O.J.; Pletnikov, M.V.; Lee, F.S.; Bhattacharyya, S.; Melis, M. Cannabis and the Developing Brain: Insights into Its Long-Lasting Effects. J. Neurosci. 2019, 39, 8250–8258. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Cohen, K.; Weinstein, A.M. The Effects of Cannabinoids on Executive Functions: Evidence from Cannabis and Synthetic Cannabinoids—A Systematic Review. Brain Sci. 2018, 8, 40. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Loke, Y.K.; Price, D.; Herxheimer, A. Systematic reviews of adverse effects: Framework for a structured approach. BMC Med. Res. Methodol. 2007, 7, 32. [Google Scholar] [CrossRef] [Green Version]
- Harada, C.N.; Love, M.N.; Triebel, K. Normal cognitive aging. Clin. Geriatr. Med. 2013, 29, 737–752. [Google Scholar] [CrossRef] [Green Version]
- Diamond, A. Executive functions. Annu. Rev. Psychol. 2013, 64, 135–168. [Google Scholar] [CrossRef] [Green Version]
- Haney, M.; Evins, A.E. Does Cannabis Cause, Exacerbate or Ameliorate Psychiatric Disorders? An Oversimplified Debate Discussed. Neuropsychopharmacology 2015, 41, 393–401. [Google Scholar] [CrossRef] [Green Version]
- Bossong, M.G.; Jager, G.; Bhattacharyya, S.; Allen, P. Acute and non-acute effects of cannabis on human memory function: A critical review of neuroimaging studies. Curr. Pharm. Des. 2014, 20, 2114–2125. [Google Scholar] [CrossRef]
- Pope, H.G.; Gruber, A.J.; Yurgelun-Todd, D. Residual neuropsychologic effects of cannabis. Curr. Psychiatry Rep. 2001, 3, 507–512. [Google Scholar] [CrossRef]
- Stuchlik, A.; Sumiyoshi, T. Cognitive Deficits in Schizophrenia and Other Neuropsychiatric Disorders: Convergence of Preclinical and Clinical Evidence. Front. Behav. Neurosci. 2014, 8, 444. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Colizzi, M.; Murray, R. Cannabis and psychosis: What do we know and what should we do? Br. J. Psychiatry 2018, 212, 195–196. [Google Scholar] [CrossRef] [PubMed]
- Appiah-Kusi, E.; Wilson, R.; Colizzi, M.; Foglia, E.; Klamerus, E.; Caldwell, A.; Bossong, M.G.; McGuire, P.; Bhattacharyya, S. Childhood trauma and being at-risk for psychosis are associated with higher peripheral endocannabinoids. Psychol. Med. 2019, 1–10. [Google Scholar] [CrossRef] [PubMed]
- O’Neill, A.; Wilson, R.; Blest-Hopley, G.; Annibale, L.; Colizzi, M.; Brammer, M.; Giampietro, V.; Bhattacharyya, S. Normalization of mediotemporal and prefrontal activity, and mediotemporal-striatal connectivity, may underlie antipsychotic effects of cannabidiol in psychosis. Psychol. Med. 2020, 2020, 1–11. [Google Scholar] [CrossRef] [PubMed]
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Colizzi, M.; Tosato, S.; Ruggeri, M. Cannabis and Cognition: Connecting the Dots towards the Understanding of the Relationship. Brain Sci. 2020, 10, 133. https://doi.org/10.3390/brainsci10030133
Colizzi M, Tosato S, Ruggeri M. Cannabis and Cognition: Connecting the Dots towards the Understanding of the Relationship. Brain Sciences. 2020; 10(3):133. https://doi.org/10.3390/brainsci10030133
Chicago/Turabian StyleColizzi, Marco, Sarah Tosato, and Mirella Ruggeri. 2020. "Cannabis and Cognition: Connecting the Dots towards the Understanding of the Relationship" Brain Sciences 10, no. 3: 133. https://doi.org/10.3390/brainsci10030133